Comparison of the Efficacy and Safety of Topical Minoxidil and Topical Alfatradiol in the Treatment of Androgenetic Alopecia in Women

April 2007 in “ Journal der Deutschen Dermatologischen Gesellschaft ”

Ulrike Blume-Peytavi, Christian Kunte, Andreas Krisp, Natalie Garcia Bartels, U. Ellwanger, Rolf Hoffmann

topical minoxidil topical alfatradiol androgenetic alopecia hair density hair thickness Rogaine

TLDR Minoxidil works better for female hair loss than alfatradiol, both safe.

This study compared the effectiveness and safety of topical minoxidil and topical alfatradiol in treating androgenetic alopecia in women. The study found that minoxidil was more effective in increasing hair density and thickness compared to alfatradiol. Both treatments were well tolerated with no side effects reported. The study involved 103 patients and was conducted over 12 months.

View this study on onlinelibrary.wiley.com →

Discuss this study in the Community →

Research cited in this study

12 / 12 results

research Alfatradiol (0.025%) - An Effective and Safe Treatment Option for Androgenetic Alopecia in Women and Men

10 citations, December 2005 in “Aktuelle Dermatologie”

Alfatradiol (0.025%) is an effective and safe treatment for hair loss in both women and men.

research Trichoscan: What Is New?

33 citations, January 2005 in “Dermatology”

Trichoscan is a reliable method for measuring hair growth and monitoring treatment effectiveness in hair loss.

research A Randomized, Placebo-Controlled Trial of 5% and 2% Topical Minoxidil Solutions in the Treatment of Female Pattern Hair Loss

219 citations, March 2004 in “Journal of The American Academy of Dermatology”

5% and 2% minoxidil solutions effectively promote hair growth and reduce hair loss, with 5% being slightly more effective but having more side effects.

research Effects of Minoxidil 2% vs. Cyproterone Acetate Treatment on Female Androgenetic Alopecia: A Controlled, 12-Month Randomized Trial

149 citations, June 2002 in “British Journal of Dermatology”

Minoxidil works better for female hair loss, but cyproterone reduces scalp oiliness and causes menstrual issues.

research Androgenetic Alopecia in Men and Women

77 citations, March 2001 in “Clinics in Dermatology”

Androgenetic alopecia involves genetics, hormones, and can be treated with medications or surgery.

research Hair Density, Hair Diameter, and the Prevalence of Female Pattern Hair Loss

234 citations, February 2001 in “British Journal of Dermatology”

FPHL affects hair density and diameter, causing visible hair loss in older women.

research Male Pattern Hair Loss: Prevention Rather Than Regrowth

6 citations, October 2000 in “International Journal of Dermatology”

Preventing hair loss is more effective than regrowth; oral finasteride is a realistic option.

Changes in Hair Weight and Hair Count in Men with Androgenetic Alopecia After Application of 5% and 2% Topical Minoxidil, Placebo, or No Treatment

research Changes in Hair Weight and Hair Count in Men with Androgenetic Alopecia After Application of 5% and 2% Topical Minoxidil, Placebo, or No Treatment

115 citations, November 1999 in “Journal of The American Academy of Dermatology”

Minoxidil increases hair weight and count temporarily in men with hair loss.

research Hair Problems in Women: A 1997 Study on Prevalence, Psychological Impact, and Treatment Approaches

37 citations, January 1997 in “Clinics in Dermatology”

Hair problems are common and distressing for women, but increasing knowledge of treatments offers hope.

research Androgenetic Alopecia in the Female: Treatment with 2% Topical Minoxidil Solution

26 citations, March 1994 in “Archives of Dermatology”

research Use of Topical Minoxidil Therapy for Androgenetic Alopecia in Women

58 citations, October 1993 in “International Journal of Dermatology”

Minoxidil helps hair growth and reduces shedding in women.

research Classification of the Types of Androgenetic Alopecia (Common Baldness) Occurring in the Female Sex

666 citations, September 1977 in “British Journal of Dermatology”

Common baldness, also known as Androgenetic Alopecia, is caused by a combination of genetic factors and hormones called androgens.

Related Research

7 / 7 results

research A Survey of Patient Attitudes Towards Topical Minoxidil in the Treatment of Hair Loss

1 citations, October 2022 in “PubMed”

Patients generally have positive attitudes towards using topical Minoxidil for hair loss treatment.

research Sisaipho Alopecia Areata Treated With Tofacitinib and Oral Minoxidil

1 citations, August 2022 in “JAAD case reports”

Tofacitinib and oral minoxidil may help treat Sisaipho alopecia areata.

research Identification of the Sulfotransferase Iso-Enzyme Primarily Responsible for the Bio-Activation of Topical Minoxidil

2 citations, June 2019 in “PubMed”

A specific enzyme that activates the hair growth medication minoxidil when applied to the skin was identified.

research The Efficacy of Topical Minoxidil for Non-Scarring Alopecia: A Systematic Review

1 citations, February 2019 in “PubMed”

Minoxidil is effective in treating various types of hair loss and can improve quality of life, with combination therapies showing increased effectiveness.

research Androgenetic Alopecia and Its Remedies: A Review

August 2014 in “Journal of drug discovery and therapeutics”

research Treatment of Female Pattern Hair Loss with a Combination of Spironolactone and Minoxidil

21 citations, January 2007 in “Australasian Journal of Dermatology”

Spironolactone and minoxidil together effectively treat female pattern hair loss.

research Topical Minoxidil in the Treatment of Alopecia Areata

80 citations, October 1983 in “BMJ”

Minoxidil helps hair regrowth in alopecia patients, with 16 having good results and no side effects.